Women's cancer drugs

These companies develop or sell drugs that treat breast, ovarian, endometrial and cervical cancers.
−4.6%
over 6 months · S&P 500 +2.6%

Key indicators

Health
50 / 100
Fragile
Solid
Price
P/E 26
Cheap
Expensive
Up over 1 year
6 of 12
Volatility
70%
Calm
Choppy
Health and price: against the other tags.